DEEPRX Trademark

Trademark Overview

On Monday, January 17, 2022, a trademark application was filed for DEEPRX with the United States Patent and Trademark Office. The USPTO has given the DEEPRX trademark a serial number of 97222557. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by DEEP RX Inc.. The DEEPRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technology research and consultancy in the field of artificial intelligence and algorithms to support the treatment of cancer
deeprx

General Information

Serial Number97222557
Word MarkDEEPRX
Filing DateMonday, January 17, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7444084
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesTechnology research and consultancy in the field of artificial intelligence and algorithms to support the treatment of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code042
First Use Anywhere DateSunday, May 1, 2022
First Use In Commerce DateSunday, May 1, 2022

Trademark Owner History

Party NameDEEP RX Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15213
Party NameDEEP RX Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15213
Party NameDEEP RX Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15213

Trademark Events

Event DateEvent Description
Thursday, January 20, 2022NEW APPLICATION ENTERED
Friday, January 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 25, 2022ASSIGNED TO EXAMINER
Wednesday, November 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 12, 2023EXAMINERS AMENDMENT -WRITTEN
Sunday, March 12, 2023EXAMINERS AMENDMENT E-MAILED
Sunday, March 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, March 12, 2023EXAMINER'S AMENDMENT ENTERED
Sunday, March 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 1 FILED
Monday, January 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, March 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 6, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 7, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, March 7, 2024PETITION TO REVIVE-GRANTED
Thursday, March 7, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, March 7, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, March 7, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, March 7, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, April 17, 2024SOU EXTENSION 1 GRANTED
Monday, April 15, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 4, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, May 3, 2024USE AMENDMENT FILED
Friday, May 3, 2024TEAS STATEMENT OF USE RECEIVED
Monday, May 6, 2024STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

deeprx algorithms support treatment cancer intelligence artificial research consultancy field technology